ImClone/Bristol Seek Priority Review For Erbitux Head And Neck Cancer Indication

Erbitux sBLA filing for head and neck cancer follows independent confirmatory review of Phase III trial.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet